The annual Bioengineering High School Competition, run by our Bioengineering Honor Society, featured a keynote speech by Professor Tejal Desai, BioE PhD alumna and Chair of the UCSF Department of Bioengineering & Therapeutic Sciences. Read more about the competition at the UCSF School of Pharmacy.
A team of BioE Master of Engineering students is working on aging and rejuvenation in the Conboy Lab.
The capstone team of Darya Fadavi, Jeffrey Feng, and Noreen Wauford was one of only three teams to win Accelerator Awards in the UCSF Surgical Innovations Shark Tank event. They will receive $25,000 in seed funding plus engineering and development support to advance their project, “Quantitative Assessment of Degree & Spatial Extent of Pain Nerve Block.” They were the only winning team with student members, and co-presented with their UCSF mentors, Professors Matthew Haight and Merlin Larson.
Bioengineering Master of Engineering students are developing a revolutionary breast cream to help mothers continue breastfeeding their newborn children.
mFluiDx, a startup founded by BioE PhD alum Charlie Yeh and currently in the CITRIS Foundry incubator, has published their development of a portable, self-powered, low-cost nucleic acid detection chip. This simple chip allows rapid quantitative digital nucleic acid detection directly from small human blood samples, an alternative to real-time PCR testing in remote or low-resource settings.
Circulating tumor cells (CTCs) are detached primary cancer cells found in the circulatory system that are implicated in the metastasis of cancer. Herr and collaborators have developed a microfluidic western blot for an 8-plex protein panel for individual CTCs, derived from estrogen receptor positive breast cancer patients, that advances the state of the art in CTC characterization with tiny sample sizes.
See how students in bioengineering and other fields are working at the intersection of design and health at the Jacobs Institute for Design Innovation.
A capstone team of bioengineering MEng students is developing nanocarriers to deliver medicine to inaccessible regions of the brain to treat neurologic and brain-related diseases.